Literature DB >> 26971127

Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons.

Matthew D Cykowski1, Hidehiro Takei2, Linda J Van Eldik2, Frederick A Schmitt2, Gregory A Jicha2, Suzanne Z Powell2, Peter T Nelson2.   

Abstract

Transactivating responsive sequence (TAR) DNA-binding protein 43-kDa (TDP-43) pathology has been described in various brain diseases, but the full anatomical distribution and clinical and biological implications of that pathology are incompletely characterized. Here, we describe TDP-43 neuropathology in the basal forebrain, hypothalamus, and adjacent nuclei in 98 individuals (mean age, 86 years; median final mini-mental state examination score, 27). On examination blinded to clinical and pathologic diagnoses, we identified TDP-43 pathology that most frequently involved the ventromedial basal forebrain in 19 individuals (19.4%). As expected, many of these brains had comorbid pathologies including those of Alzheimer disease (AD), Lewy body disease (LBD), and/or hippocampal sclerosis of aging (HS-Aging). The basal forebrain TDP-43 pathology was strongly associated with comorbid HS-Aging (odds ratio = 6.8, p = 0.001), whereas there was no significant association between basal forebrain TDP-43 pathology and either AD or LBD neuropathology. In this sample, there were some cases with apparent preclinical TDP-43 pathology in the basal forebrain that may indicate that this is an early affected area in HS-Aging. We conclude that TDP-43 pathology in the basal forebrain is strongly associated with HS-Aging. These results raise questions about a specific pathogenetic relationship between basal forebrain TDP-43 and non-HS-Aging comorbid diseases (AD and LBD).
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer disease; Basal forebrain; Frontotemporal lobar degeneration; Hippocampal sclerosis; TDP-43.

Mesh:

Substances:

Year:  2016        PMID: 26971127      PMCID: PMC5009476          DOI: 10.1093/jnen/nlw014

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Authors:  Jonathan P Ling; Olga Pletnikova; Juan C Troncoso; Philip C Wong
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

3.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature.

Authors:  Eseosa T Ighodaro; Gregory A Jicha; Frederick A Schmitt; Janna H Neltner; Erin L Abner; Richard J Kryscio; Charles D Smith; Taylor Duplessis; Sonya Anderson; Ela Patel; Adam Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

5.  Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.

Authors:  Naomi Kouri; Kenichi Oshima; Makio Takahashi; Melissa E Murray; Zeshan Ahmed; Joseph E Parisi; Shu-Hui C Yen; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

6.  TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.

Authors:  Stacy J Arnold; Brittany N Dugger; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2013-04-20       Impact factor: 17.088

7.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.

Authors:  Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis.

Authors:  Matthew D Cykowski; Hidehiro Takei; Paul E Schulz; Stanley H Appel; Suzanne Z Powell
Journal:  Acta Neuropathol Commun       Date:  2014-12-24       Impact factor: 7.801

View more
  21 in total

1.  Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Authors:  Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson
Journal:  Arch Pathol Lab Med       Date:  2017-05-03       Impact factor: 5.534

2.  Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.

Authors:  Peter T Nelson; Yuriko Katsumata; Kwangsik Nho; Sergey C Artiushin; Gregory A Jicha; Wang-Xia Wang; Erin L Abner; Andrew J Saykin; Walter A Kukull; David W Fardo
Journal:  Acta Neuropathol       Date:  2016-11-04       Impact factor: 17.088

3.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

4.  Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Ju Gao; Luwen Wang; Jingjing Liang; Xinglong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-25

5.  OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.

Authors:  Xuping Li; Lin Wang; Matthew Cykowski; Tiancheng He; Timothy Liu; Joshua Chakranarayan; Andreana Rivera; Hong Zhao; Suzanne Powell; Weiming Xia; Stephen T C Wong
Journal:  EBioMedicine       Date:  2020-01-10       Impact factor: 8.143

6.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

7.  TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.

Authors:  S Koga; W-L Lin; R L Walton; O A Ross; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2018-05-09       Impact factor: 8.090

8.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

Review 9.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

10.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.